Depomed sinks on dismal drug news - Elizabeth Harrow

Sign Up | Log In | What is SocialPicks?

Depomed sinks on dismal drug news
Oct 12, 2009 04:30 PM UTC

Elizabeth Harrow

Return	Risk
+29.84%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
DEPO	n/a

Via BloggingStocks:

Filed under: Bad news

Depomed Inc. (NASDAQ: DEPO) opened Monday on a loss of nearly 50%, as traders panned the company's clinical trial results for Serada. The drug, which is intended to treat hot flashes related to menopause, met only one one of four co-primary goals in late-stage trials after 12 weeks.

Depomed was hoping to prove that Serada could help patients achieve a "statistically significant reduction in the frequency and severity of menopausal hot flashes." However, the company confessed that the placebo effect was unexpectedly high in clinical studies.

Continue reading Depomed sinks on dismal drug news

Depomed sinks on dismal drug news originally appeared on BloggingStocks on Mon, 12 Oct 2009 11:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Read the rest of original post »

Comments (1)

Add Comment

yavuzbaba

N/A

1 point commented 461 days ago reply

sohbet -
türkü hikayeleri

sohbet -

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.